Mohammad Obaidul Hoque

7PUBLICATIONS
14CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 14, 2025
Epigenetic Treatment Alters Immune-Related Gene Signatures to Increase the Sensitivity of Anti PD-L1 Drugs.

Chonji Fukumoto, Pritam Sadhukhan, Masahiro Shibata

|Oct 23, 2021
Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers.

Sarah E Mudra, Pritam Sadhukhan, M Talha Ugurlu

|Dec 23, 2020
Effect of COVID-19 on Lungs: Focusing on Prospective Malignant Phenotypes.

Pritam Sadhukhan, M Talha Ugurlu, Mohammad O Hoque

|Aug 21, 2020
GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma.

Masamichi Hayashi, Elisa Guida, Yoshikuni Inokawa

|May 30, 2019
Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer.

Masahiro Shibata, Mohammad Obaidul Hoque

|Apr 27, 2018
A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy.

Masahiro Shibata, Kendall Ham, Mohammad Obaidul Hoque

Pageof 2